Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
OpenAI in talks with Samsung to power AI features, report says
-
4
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
S. Korea not to attend Sado mine memorial: foreign ministry
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
[DISCLOSURE] Hanwha Ace Special Purpose Acquisition 1 (214680) announced on June 27 that it will merge DRTech into the firm at 1:6.2390476 ratio. When the merger is complete, the largest shareholder will be Yoon Jeong-gi and six others (28.05 percent), the current largest shareholders of the medical instrument manufacturer.
Korea Exchange has suspended trading of Hanwha Ace Special Purpose Acquisition 1, the SPC announced in a separate statement.
Korea Exchange has suspended trading of Hanwha Ace Special Purpose Acquisition 1, the SPC announced in a separate statement.
